Monopar Therapeutics Inc.

NasdaqCM:MNPR 주식 보고서

시가총액: US$81.2m

Monopar Therapeutics 관리

관리 기준 확인 2/4

Monopar Therapeutics CEO는 Chandler Robinson, Dec2014 에 임명되었습니다 의 임기는 9.92 년입니다. 총 연간 보상은 $ 1.78M, 32.6% 로 구성됩니다. 32.6% 급여 및 67.4% 보너스(회사 주식 및 옵션 포함). 는 $ 886.23K 가치에 해당하는 회사 주식의 1.09% 직접 소유합니다. 886.23K. 경영진과 이사회의 평균 재임 기간은 각각 5.7 년과 8.8 년입니다.

주요 정보

Chandler Robinson

최고 경영자

US$1.8m

총 보상

CEO 급여 비율32.6%
CEO 임기9.9yrs
CEO 소유권1.1%
경영진 평균 재임 기간5.7yrs
이사회 평균 재임 기간8.8yrs

최근 관리 업데이트

Recent updates

We Think Monopar Therapeutics (NASDAQ:MNPR) Needs To Drive Business Growth Carefully

Aug 13
We Think Monopar Therapeutics (NASDAQ:MNPR) Needs To Drive Business Growth Carefully

Is Monopar Therapeutics (NASDAQ:MNPR) In A Good Position To Deliver On Growth Plans?

Feb 27
Is Monopar Therapeutics (NASDAQ:MNPR) In A Good Position To Deliver On Growth Plans?

Will Monopar Therapeutics (NASDAQ:MNPR) Spend Its Cash Wisely?

Mar 02
Will Monopar Therapeutics (NASDAQ:MNPR) Spend Its Cash Wisely?

We Think Monopar Therapeutics (NASDAQ:MNPR) Needs To Drive Business Growth Carefully

Nov 16
We Think Monopar Therapeutics (NASDAQ:MNPR) Needs To Drive Business Growth Carefully

Monopar stock soars 19% as enrollment finishes in phase 2 part of oral mucositis study of Validive

Oct 05

We're Keeping An Eye On Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Rate

Jul 30
We're Keeping An Eye On Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Rate

Monopar Therapeutics (NASDAQ:MNPR) Is In A Good Position To Deliver On Growth Plans

Mar 28
Monopar Therapeutics (NASDAQ:MNPR) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Monopar Therapeutics (NASDAQ:MNPR) Will Use Its Cash Wisely

Jul 15
We're Hopeful That Monopar Therapeutics (NASDAQ:MNPR) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation

Mar 26
Here's Why We're Not Too Worried About Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation

Monopar nabs U.S. patent covering camsirubicin

Dec 22

Monopar Therapeutics selects targeted immuno-therapeutic candidate for COVID-19

Dec 10

Monopar launches validive mid-stage study in chemo-induced oral mucositis

Dec 08

Monopar Therapeutics EPS beats by $0.02

Nov 12

CEO 보상 분석

Chandler Robinson 의 보수는 Monopar Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$8m

Dec 31 2023US$2mUS$580k

-US$8m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$10m

Dec 31 2022US$2mUS$550k

-US$11m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$10m

Mar 31 2022n/an/a

-US$10m

Dec 31 2021US$1mUS$525k

-US$9m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$8m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$2mUS$504k

-US$6m

Sep 30 2020n/an/a

-US$5m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$541kUS$386k

-US$4m

Sep 30 2019n/an/a

-US$4m

Jun 30 2019n/an/a

-US$4m

Mar 31 2019n/an/a

-US$4m

Dec 31 2018US$1mUS$375k

-US$3m

Sep 30 2018n/an/a

-US$3m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$17m

Dec 31 2017US$401kUS$331k

-US$17m

보상 대 시장: Chandler 의 총 보상 ($USD 1.78M )은 US 시장( $USD 653.16K ).

보상과 수익: 회사가 수익성이 없는 동안 Chandler 의 보상이 증가했습니다.


CEO

Chandler Robinson (40 yo)

9.9yrs

테뉴어

US$1,778,655

보상

Dr. Chandler D. Robinson, M.D., MBA, MSc, Co-Founded Monopar Therapeutics Inc. in 2010 and has been Chief Executive Officer and Director since December 2014 and serves as President. Among his previous expe...


리더십 팀

이름위치테뉴어보상소유권
Christopher Starr
Co-Founder & Independent Executive Chairman of the Board9.9yrsUS$264.04k0.29%
$ 237.5k
Chandler Robinson
Co-Founder9.9yrsUS$1.78m1.09%
$ 886.2k
Andrew Cittadine
Chief Operating Officer3.4yrsUS$911.14k0.78%
$ 629.1k
Karthik Radhakrishnan
CFO, Principal Accounting Officer & Principal Financial Officerless than a year데이터 없음0.030%
$ 24.5k
Patrice Rioux
Acting Chief Medical Officer7.9yrs데이터 없음데이터 없음

5.7yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: MNPR 의 관리팀은 노련하고 경험 (평균 재직 기간 5.7 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Christopher Starr
Co-Founder & Independent Executive Chairman of the Board9.9yrsUS$264.04k0.29%
$ 237.5k
Chandler Robinson
Co-Founder9.9yrsUS$1.78m1.09%
$ 886.2k
Michael Brown
Independent Director9.9yrsUS$126.04k0.92%
$ 744.4k
Raymond Anderson
Independent Director7.6yrsUS$136.54k0.10%
$ 84.8k
Arthur Klausner
Independent Director7.3yrsUS$128.54k0.12%
$ 97.4k
Kim Tsuchimoto
Director1.7yrsUS$848.44k0.22%
$ 181.3k

8.8yrs

평균 재임 기간

65.5yo

평균 연령

경험이 풍부한 이사회: MNPR 의 이사회경험(평균 재직 기간 8.8 년)으로 간주됩니다.